[Follow-up, therapeutic education, and pharmacologic treatments of patients with type 2 diabetes. Various critical views].
Several factors have to be taken into account for successful therapeutic patient education: patients' acceptance of the illness; an interactive educational process, the inclusion of therapeutic objectives in the short, medium and long-term which should be planned with the patient. There are numerous facets in the treatment of diabetes, but the common denominator is the dietary programme coupled with daily physical activity. This is the condition sine qua non to be included before the introduction of any pharmacological treatment. The benefits of this latter treatment are: 1) insulin substitution with insulin analogue responding especially quickly, thereby stopping the glycaemic level from falling; 2) insulin secretagogues (Sulfonylurea, Glinides, [Novonorm, Starlix]); 3) agents which raise the sensibility to insulin (glitazones, [Avandia], biguanides); 4) molecules which interfere with the absorption of the glucose at the digestive level (biguanides and alphaglucosidase inhibitors).
Assal
Jean-Philippe
JP
Division d'enseignement thérapeutique pour maladies chroniques (DETMC) Hôpital Cantonal Universitaire, 1211 Genève 14.
Dayer-Metroz
Marie-Dominique
MD
D003920:Diabetes Mellitus / Q000188:drug therapy / Q000628:therapy*; D005500:Follow-Up Studies; D006801:Humans; D010353:Patient Education as Topic